233
Participants
Start Date
July 13, 2018
Primary Completion Date
October 21, 2019
Study Completion Date
October 21, 2019
ASP4345
oral administration
placebo
oral administration
risperidone
oral or depot administration
quetiapine
oral administration
olanzapine
Oral or depot administration
ziprasidone
Oral or depot administration
aripiprazole
Oral or depot administration
brexpiprazole
Oral administration
paliperidone
Oral or depot administration
lurasidone
Oral administration
New York State Psychiatric Institute, New York
Manhattan Psychiatric Center's 125th Street Clinic, New York
SPRI Clinical Trials, LLC, Brooklyn
CNS Research Science, Inc., Jamaica
Finger Lakes Clinical Research, Rochester
Radiant Research, Inc., Atlanta
Atlanta Center for Medical Research, Atlanta
Midwest Clinical Research Center, Dayton
Michigan Clinical Research Institute PC, Ann Arbor
Cherry Street Services, Inc., Grand Rapids
Alam Medical Research Inc., Chicago
Uptown Research Institute, Chicago
Arch Clinical Trials, LLC, St Louis
Pillar Clinical Research, LLC, Richardson
InSite Clinical Research, LLC, DeSoto
Community Clinical Research, Inc., Austin
Albuquerque Neuroscience Inc., Albuquerque
Collaborative Neuroscience Network, LLC, Torrance
California Neuropsychopharmacology Clinical Research Institute-LA, LLC, Pico Rivera
CNS Research Science, Inc., Cerritos
Synergy East, Lemon Grove
California Neuropsychopharmacology Clinical Research Institute, LLC (CNRI-San Diego), San Diego
Artemis Institute for Clinical Research, San Diego
Sharp Mesa Vista Hospital, San Diego
Collaborative Neuroscience Network, LLC, Garden Grove
Pacific Research Partners, LLC, Oakland
Hassman Research Institute, Berlin
Astellas Pharma Global Development, Inc.
INDUSTRY